Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Alkaline water is being investigated by **Pharos University in Alexandria** as a non-pharmacological therapeutic mouthwash intervention for the prevention of dental caries. In clinical research settings, specifically a double-blind randomized controlled trial, alkaline water (specifically **FLO water** with a pH range of 7.6 to 8.5) is used to reduce the salivary counts of *Streptococcus mutans*, the primary bacterial pathogen responsible for tooth decay in children. The mechanism of action relies on the high pH of the water, which neutralizes the acidic environment of the oral cavity and inhibits the growth and colonization of acidogenic bacteria. This intervention is being compared against chlorhexidine, the current gold standard for oral antimicrobial rinses, to evaluate its efficacy as a safer or more natural alternative for pediatric dental health.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on alkaline water-Pharos University in Alexandria.